Loading
companiesCompany
Immunitor
Immunitor is a Mongolian biotech, founded in 2000, that makes oral tablet vaccines from heat-inactivated cells; its hepatocellular carcinoma vaccine hepcortespenlisimut-L went through phase 3 trials the company led.
Also called: Immunitor LLCImmunitor Inc.
Overview
Immunitor, based in Ulaanbaatar and founded in 2000, develops oral tablet immunotherapies made from heat-inactivated cells, including a tuberculosis vaccine and hepcortespenlisimut-L (V5) for hepatocellular carcinoma, which it tested in phase 3 trials in Mongolia registered on ClinicalTrials.gov under Immunitor as lead sponsor.
Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyGC Cell
Shares Pivotal (registrational) trial, Clinical trial, Hepatocellular carcinoma.
- CompanyVion Pharmaceuticals
- CompanyCyclacel Pharmaceuticals